Figure 2From: Early detection of doxorubicin myocardial injury by ultrasonic tissue characterization in an experimental animal model Hystopathologic analysis of myocardial samples stained with hematoxilin and eosin from control (panel A) and doxorubicin groups (8 mg/Kg- panel B; 12 mg/Kg- panel C and 16 mg/Kg- panel D). Note that vacuolar degeneration, disorganization and loss of myofibrils are more pronounced with the increment of DXR cumulative doses (panel B-D). Arrows mark points of vacuolar degeneration and intracellular edema.Back to article page